GRACEcast-084_Lung-Cancer_ALK Inhibition: Science and Early Clinical Experience by Dr. Ben Solomon
6 Visualizzazioni
• 07/30/23
0
0
Incorporare
administrator
Iscritti
http://cancergrace.org/
Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti